Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Transplantation and Cellular Therapy ; 29(2 Supplement):S367, 2023.
Article in English | EMBASE | ID: covidwho-2317329

ABSTRACT

Introduction: Survival after hematopoietic cell transplantation (HCT) has improved tremendously over the last few decades. HCT survivors are at increased risk of long-term complications and secondary cancers. This poses unique challenges to the HCT-related healthcare system given the growing need for survivorship care. Developing a HCT survivorship program with a dedicated clinic to survivors ensures equitable access to care and ongoing patient education. Herein, we describe our program survivorship model and our initial experience. Method(s): The Moffitt Cancer Center (MCC) survivorship clinic (SC) planning committee was initiated in September 2019. The SC was launched in January 2021 with the mission to provide high-quality, comprehensive, and personalized survivorship care and to empower patients and community health care providers with education and a roadmap for screening for late effects. The SC initially focused on allogeneic (allo) HCT patients and later opened to autologous (auto) HCT recipients in February 2022. HCT patients are referred by primary HCT team after HCT with an emphasis on preferred timeframe of initial SC visit no earlier than 3 months but less than 12 months from HCT. SC is located at 2 physical locations: main campus and satellite, with virtual visit options to account for the distance from MCC and COVID considerations. SC applies a consultative model. SC is staffed by dedicated advanced practice professional (APP), supervised by SC faculty. The scope of SC care includes but is not limited to prevention of infections (education, vaccinations), surveillance of late effects (endocrine, pulmonary function, cardiac, bone health), and general cancer screenings (breast, colon, skin cancer). Patients' clinical data from SC inception to August 2022 were reviewed. Result(s): From January 2021 to August 2022, a total of 138 patients were seen in SC. The majority were seen in person (62% in clinic, 38% by virtual visit). Median age was 58 years (range, 19-82). Median time to first SC visit was 21 months (range, 3-1464) after HCT. Allo HCT was the most common type of HCT seen in clinic (87%, n=120). Most common diagnoses were acute myeloid leukemia (43%, n=59), myelodysplastic syndrome (17%, n=23), and acute lymphoblastic leukemia (10%, n=14). Only 17 patients (12%) were seen in 2021 but the volume increased significantly in 2022. Currently there are more than 10 patients seen in SC per month. Conclusion(s): We report successful experience in launching a contemporary HCT SC despite the challenges of an ongoing COVID pandemic. As a stand-alone cancer center, we serve a wide geographical location with subspecialty and primary care providers dispersed throughout the community. Our consultative model and experience could provide a useful guide for other programs. In 2023, we plan to expand our SC to a broader population of patients receiving other cellular immunotherapies.Copyright © 2023 American Society for Transplantation and Cellular Therapy

2.
Journal of AAPOS ; 26(4):e31, 2022.
Article in English | EMBASE | ID: covidwho-2076287

ABSTRACT

Introduction: A paucity of data exists regarding reimbursement trends in pediatric ophthalmology, especially regarding the consequences of national policy enacted to minimize the COVID-19 pandemic's effect on access to healthcare. The purpose of this study was to evaluate monetary trends for common pediatric ophthalmology procedures among the Arizona Medicaid population, compared to Medicare data. Method(s): Publicly available Arizona Medicaid and Medicare Physician Fee Schedules from 2015-2021 were utilized. Collected data included reimbursement for common procedural and nonprocedural (examination, imaging) billing codes used in pediatric ophthalmology. Data was adjusted for inflation to 2021 dollars. Result(s): From 2015-2020, the inflation-adjusted average Arizona Medicaid and Medicare reimbursement for all procedures decreased by 9% from 2015-2020 (-2% per year) and 12% (-2% per year), respectively. From 2020-2021, average procedural Medicaid reimbursement increased by 11%, while Medicare decreased by 6%. From 2015 to 2020, average nonprocedural Medicaid and Medicare reimbursement decreased by 16% (-3% per year) and 18% (-4% per year), respectively. Average non-procedural Medicaid reimbursement increased by 8% from 2020-2021, while Medicare decreased by 2%. No significant difference was observed between Arizona and national Medicare trends (P > 0.05). Conclusion/Relevance: Arizona Medicaid and Medicare reimbursement steadily decreased from 2015-2020, but Medicaid reimbursement markedly increased from 2020-2021. This reflects a 6.2% increase in federal Medicaid funding to states enacted by Congress in 2020, which will end after the public health emergency. In light of recent decreases in outpatient utilization due to the COVID-19 pandemic, increased awareness of these trends is needed to maintain adequate access to pediatric ophthalmologic care, particularly among Medicaid enrollees. Copyright © 2022

3.
South Afr J Crit Care ; 38(1)2022.
Article in English | MEDLINE | ID: covidwho-1884656

ABSTRACT

Background: The COVID-19 pandemic has had a significant impact on healthcare systems globally as most countries were not equipped to deal with the outbreak. To avoid complete collapse of intensive care units (ICUs) and health systems as a whole, containment measures had to be instituted. In South Africa (SA), the biggest intervention was the government-regulated national lockdown instituted in March 2020. Objectives: To evaluate the effects of the implemented lockdown and institutional guidelines on the admission rate and profile of non-COVID-19 patients in a regional and tertiary level ICU in Pietermaritzburg, KwaZulu-Natal Province, SA. Methods: A retrospective analysis of all non-COVID-19 admissions to Harry Gwala and Greys hospitals was performed over an 8-month period (1 December 2019 - 31 July 2020), which included 4 months prior to lockdown implementation and 4 months post lockdown. Results: There were a total of 678 non-COVID-19 admissions over the 8-month period. The majority of the admissions were at Greys Hospital (52.4%; n=355) and the rest at Harry Gwala Hospital (47.6%; n=323). A change in spectrum of patients admitted was noted, with a significant decrease in trauma and burns admissions post lockdown implementation (from 34.2 - 24.6%; p=0.006). Conversely, there was a notable increase in non-COVID-19 medical admissions after lockdown regulations were implemented (20.1 - 31.3%; p<0.001). We hypothesised that this was due to the gap left by trauma patients in an already overburdened system. Conclusion: Despite the implementation of a national lockdown and multiple institutional directives, there was no significant decrease in the total number of non-COVID-19 admissions to ICUs. There was, however, a notable change in spectrum of patients admitted, which may reflect a bias towards trauma admissions in the pre COVID-19 era. Contributions of the study: We describe the impact of the COVID-19 pandemic on critical care services in a resource-limited setting. We also demonstrate the ongoing need for intensive care unit beds within the public sector.

4.
S Afr Med J ; 110(11): 1110-1112, 2020 10 28.
Article in English | MEDLINE | ID: covidwho-979204

ABSTRACT

BACKGROUND: Trauma care places a significant burden on the South African (SA) healthcare system, and this has not changed significantly in recent history. We speculated that the COVID-19 lockdown regulations (travel restriction and alcohol ban) would affect trauma patterns. OBJECTIVES: To compare the burden and nature of trauma over the COVID-19 lockdown period with the equivalent period over the past 5 years using routinely collected data from the Pietermaritzburg Metropolitan Trauma Service in KwaZulu-Natal Province, SA. METHODS: All trauma patients admitted to Grey's Hospital in Pietermaritzburg between 23 March 2015 and 31 May 2020 were identified and reviewed. RESULTS: A total of 8 859 trauma patients were admitted over the 6-year period, with a total of 1 676 admitted during the periods 23 March - 31 May. These 1 676 formed the study cohort. Of these patients, 998 had sustained blunt trauma, 665 penetrating trauma, and 13 a combination of blunt and penetrating trauma. A total of 14 categories of blunt trauma were reviewed, of which the three most common were assault, motor vehicle accidents (MVAs) and pedestrian vehicle accidents (PVAs). Between 23 March and 31 May 2020, a total of 23 patients were victims of blunt assault. The median number of assault victims over the equivalent period during the previous 5 years was 48. The 5 preceding years had a median of 56 MVAs and 33 PVAs, compared with 23 and 10 during the lockdown. The median number of gunshot wound (GSW) victims for the preceding years was 41, compared with 30 during the lockdown. During the lockdown, 24 stab wound victims were admitted, compared with a median of 73 for the preceding years. The proportion of females who sustained penetrating trauma and blunt assault increased significantly during the lockdown. The proportion of females sustaining a GSW or blunt trauma secondary to an MVA remained constant. CONCLUSIONS: The study showed that during the period of lockdown in SA there was a significant decrease in MVAs, PVAs and interpersonal violence. Assaults involving a knife seemed to decrease dramatically, but the rate of GSWs remained constant.


Subject(s)
Accidents, Traffic/statistics & numerical data , COVID-19 , Sex Distribution , Violence/statistics & numerical data , Wounds, Gunshot/epidemiology , Wounds, Nonpenetrating/epidemiology , Wounds, Stab/epidemiology , Female , Humans , Male , Pedestrians , SARS-CoV-2 , South Africa/epidemiology , Wounds and Injuries/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL